Key facts
| Price (PPV) | 160.90 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | irbesartanhydrchlorothiazide |
| Class | Agents acting on the renin-angiotensin system |
| ATC code | C09DA04 |
| Manufacturer | PHI |
| Presentation | Boite de 30 |
| Nature | Médicament |
| Hospital price | 100.50 MAD |
| Data collected on | 9/8/2026 |
Indications
Traitement de l'hypertension artérielle essentielle lorsque l'effet d'une monothérapie reste insuffisant. Traitement initial en cas d'hypertension prononcée, lorsqu'un contrôle rapide de la pression artérielle (en termes de jours ou de semaines) est de première importance clinique.
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
In Morocco, 11 other products contain the same active substance as Irphi Plus 300 mg / 12.5 mg (Irbesartan | Hydrchlorothiazide), at the same strength and in the same dosage form. For the same pack size (Boite de 30), the cheapest is Coavacor 300 mg / 12.5 mg (POLYMEDIC) at 158.20 MAD, i.e. 2 % less than Irphi Plus 300 mg / 12.5 mg (160.90 MAD). The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
Same pack size
| Product | Manufacturer | Pack | PPV | Unit price | Difference |
|---|---|---|---|---|---|
| Coavacor 300 mg / 12.5 mg | POLYMEDIC | Boite de 30 | 158.20 MAD | 5.27 / unit | −2 % |
| Novortan Plus 300 mg / 12.5 mg | NOVOPHARMA | Boite de 30 | 158.20 MAD | 5.27 / unit | −2 % |
| Co-Arapro 300 mg / 12.5 mg | ZENITH PHARMA | Boite de 30 | 169.30 MAD | 5.64 / unit | — |
Other pack sizes
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Co-Arapro 300 mg / 12.5 mg | ZENITH PHARMA | Boite de 10 | 60.70 MAD | 6.07 / unit |
| Irphi Plus 300 mg / 12.5 mg | PHI | Boite de 10 | 60.70 MAD | 6.07 / unit |
| Co-Icard 300 mg / 12.5 mg | COOPER PHARMA | Boite de 14 | 85 MAD | 6.07 / unit |
| Co-Irvel 300 mg / 12.5 mg | AFRIC-PHAR | Boite de 14 | 85 MAD | 6.07 / unit |
| Irphi Plus 300 mg / 12.5 mg | PHI | Boite de 20 | 88.50 MAD | 4.43 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Irphi Plus 300 mg / 12.5 mg
Irphi Plus 300 mg / 12.5 mg belongs to the agents acting on the renin-angiotensin system therapeutic class. In Morocco, this drug is marketed by PHI and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Irphi Plus 300 mg / 12.5 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Irphi Plus 300 mg / 12.5 mg
Answers to common questions from Moroccan patients about this drug.